Madrid, 28031, Spain
NCT Number: NCT00894777
Study Evaluating Management of Patients With Moderate and Severe Psoriasis
This is an observational, naturalistic, multicenter, retrospective study to describe the therapeutic management of patients with moderate and severe psoriasis under treatment with topical and/or systemic drugs in usual clinical practice in Spain.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Main Inclusion Criteria:
·Over 18 years of age.·Diagnosed with moderate or severe psoriasis.·Initiated treatment with topical and/or systemic treatment between two and five years before enrollment in the study. ·Has a clinical record at the dermatologist office.
Main Exclusion Criteria:
·Currently participating in a clinical study. ·Clinical record lacks minimum data required for observational analysis.
Treatment and study plan
Clinical record review
OtherPrimary outcomes
-
Descriptive analysis of the therapeutic management of patients with moderate and severe psoriasis under treatment with topical and/or systemic drugs including sequence, doses and duration of treatment.
Time frame: 4 months
Secondary outcomes
-
Comparison of therapeutic management depending on patients' disease severity, using absolute and relative frequencies for qualitative variables and centralization and dispersion measures (mean, SD, median, minimum, maximum..) for quantitative variables.
Time frame: 4 months
Sponsors and collaborators
Lead sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Industry
Registry information
Official study title
Management of Patients With Moderate and Severe Psoriasis Under Treatment With Topical and/or Systemic Drugs
Important dates
- Study start
- 2009
- Primary completion
- 2009
- Study completion
- 2009
- First posted
- May 7, 2009
- Registry last updated
- Nov 22, 2010
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)
NCT01778569
Cardiovascular Disease, Cardiovascular Diseases
Bethesda, Maryland, United States
View Trial DetailsChinese Medicine for Patients With Psoriasis
NCT05295979
Psoriasis, Skin Diseases
Hong Kong
View Trial DetailsAnti-Inflammatory Effects of Time-Restricted Feeding
NCT04728165
Psoriasis, Skin Diseases
Bethesda, Maryland, United States
View Trial DetailsHPP737 in Adult Patients With Plaque Psoriasis
NCT07712731
Psoriasis, Skin Diseases
Baotou, China
View Trial Details